Clinical MS Research Group
Our single objective: to prevent and reverse disability for everyone with multiple sclerosis, neuromyelitis optica and MOG associated disease.
Research Themes
Cambridge Clinical Multiple Sclerosis Research Group is achieving this objective through six themes:
-
Personalising Treatments through Big Data and AI
-
Discovering and Proving New Repair therapies
-
Our Visual and MRI Outcome Development Program
-
Studying Children with MS, NMO and related conditions
-
Study ageing in multiple sclerosis
-
Measuring and sustainably addressing healthcare inequalities.
Currently our work is focused on:
-
Improving the availability of data in electonic health records in the UK for MS researchers
-
Using real-world data to answer important questions about how best to use MS therapies
-
Exploring how best to measure remyelination in adults and children with MS
-
Investigating natural remyelination in people with MS
-
Doing clinical trials to identify drugs which promote endogenous remyelination in people with MS
Read more here.
Featured News
Dr Will Brown and Dr Nicholas Cunniffe Deliver MS Academy Roadshow Presentations in Norwich
1st May 2026
Two of our research group leads, Dr Will Brown and Dr Nicholas Cunniffe, had the pleasure of presenting at the MS Academy Roadshow in Norwich yesterday.
Read more here.
Professor Alasdair Coles to Deliver MS Society Annual Research Lecture 2026
24th April 2026
We are proud and excited to share that on Tuesday 19 May, at the The Royal Society in London, Professor Alasdair Coles will deliver the MS Society's Annual Research Lecture 2026.
Read more here.
Dr Nicholas Cunniffe Joins Multiple Sclerosis Auckland Remyelination Research Webinar
10th April 2026
Our Clinical Trials and Remyelination Group lead, Dr Nicholas Cunniffe, was recently offered the opportunity to participate in a live webinar on remyelination research, hosted by Multiple Sclerosis Auckland in New Zealand.
Read more here.
